TALISA SINGLETARY: Open Payments
NPI 1821539495 · LAURINBURG, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 28 payments from 9 companies in 2025. Trend: 2023 $646 · 2024 $482 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $229 |
| Exact Sciences Corporation | 4 | $168 |
| Lilly USA, LLC | 6 | $97 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Corcept Therapeutics | 1 | $25 |
| ABBVIE INC. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: The Cologuard Plus Collection Kit, Wegovy, MOUNJARO, FARXIGA, AIRSUPRA, Rybelsus, Ozempic, Korlym.
Industry payments across NC — which companies pay providers there.
